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A B S T R A C T   
Background and purpose: The COVID-19 pandemic has imposed changes in radiotherapy (RT) departments 
worldwide. Medical physicists (MPs) are key healthcare professionals in maintaining safe and effective RT. This 
study reports on MPs experience during the first pandemic peak and explores the consequences on their work. 
Methods: A 39-question survey on changes in departmental and clinical practice and on the impact for the future 
was sent to the global MP community. A total of 433 responses were analysed by professional role and by country 
clustered on the daily infection numbers. 
Results: The impact of COVID-19 was bigger in countries with high daily infection rate. The majority of MPs 
worked in alternation at home/on-site. Among practice changes, implementation and/or increased use of 
hypofractionation was the most common (47% of the respondents). Sixteen percent of respondents modified 
patient-specific quality assurance (QA), 21% reduced machine QA, and 25% moved machine QA to weekends/ 
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evenings. The perception of trust in leadership and team unity was reversed between management MPs (towards 
increased trust and unity) and clinical MPs (towards a decrease). Changes such as home-working and increased 
use of hypofractionation were welcomed. However, some MPs were concerned about pressure to keep negative 
changes (e.g. weekend work). 
Conclusion: COVID-19 affected MPs through changes in practice and QA procedures but also in terms of trust in 
leadership and team unity. Some changes were welcomed but others caused worries for the future. This report 
forms the basis, from a medical physics perspective, to evaluate long-lasting changes within a multi-disciplinary 
setting.   
1. Introduction 
The outbreak of the Severe Acute Respiratory Syndrome CoronaVirus 
2 (SARS-CoV-2) causing Coronavirus disease 2019 (COVID-19) is an 
extreme event with complex spread-dynamics [1]. The crisis has pro-
duced different infection rates and strain levels on the healthcare sys-
tems of different countries. Radiotherapy (RT) has been recognized as an 
essential non-elective treatment for many tumour entities [2,3]. Cancer 
patients are at increased risk of COVID-19-related complications [4]. 
Although RT services continued, important changes were implemented 
rapidly to enhance patient and staff protection against infection, 
including treatment delay or RT schedule alterations [2,3,5–12]. This 
also affected medical physicists (MPs), who are key healthcare pro-
fessionals in sustaining safe, effective, and efficient RT under constraints 
of social distancing and national/regional pandemic-related guidelines 
[13]. 
In addition to legal requirements for MPs presence at the hospital, 
which may differ internationally, Whitaker et al. distinguished four 
types of tasks from a practical standpoint [14]. First, direct patient- 
facing tasks, such as brachytherapy, first fraction verification for com-
plex treatments and in-vivo dosimetry represent a small but vital portion 
of the workload requiring MPs on-site during treatment hours. Second, 
some measurement-based quality assurance (QA) requires on-site pres-
ence but can be performed out of treatment hours. Third, treatment 
planning-related, quality management, and administrative tasks can 
often be done remotely. Fourth, project planning, education, training 
and research can often be performed remotely or potentially postponed 
for clinical staff. 
Researchers that mostly have type-4 tasks were most likely to work 
from home while clinical MPs needed to work on-site and/or on shift 
[13–15]. Management MPs were involved in decision making and 
liaising between hospital administration and clinical staff [9]. Thus, MPs 
may have had widely diverse experiences during COVID-19 due to 
different roles and responsibilities. 
Most RT service changes were aimed at limiting patient presence at 
the hospital (e.g. RT postponement when clinically supported, or 
hypofractionation) and to limit interaction between team-members (e.g. 
shift work) [2,5–10,16–18]. These were considered a “contingency 
standard of care” in an “early pandemic scenario” while more drastic 
resource shortages and patient triage were anticipated in a “second 
(later) pandemic scenario” [19,20]. MPs have less patient contact than 
radiation oncologists, radiation therapists (RTTs) and nurses. They 
perform many “behind the scenes” tasks, e.g. planning and patient- 
specific QA (PSQA), easily overlooked when establishing guidelines 
limiting patient contact. Whereas new publications are exploring the 
aftermath and lessons learned for future clinical practice [18,21–23] 
with potentially more patient-centric research and streamlined admin-
istrative and regulatory procedures [24], the impact for MPs is unclear. 
This study presents a global survey of MPs experience during the first 
pandemic wave (March-June 2020). We aim to understand the different 
challenges faced by MPs in different roles and countries and the po-
tential impact for future practice. Results were analysed for three 
country clusters based on daily number of infections in order to link the 
spread-dynamic and early/late pandemic scenarios to changes in med-
ical physics practice. Results are also reported by professional role 
(management vs clinical MP) where relevant. From this study we can 
infer how to adapt to future crises, but also integrate potentially positive 
changes to keep for the future. 
2. Materials and methods 
A web-based questionnaire (Supplementary material A.I) was 
distributed to ESTRO’s physics members via e-mail (2500 recipients) 
and the broader medical physics community via social media. It con-
tained 39 questions on demographics (questions 1–12), department 
organisation (13–20), changes in practice (21–31), morale and mental 
health (32–33) and expected future impacts (34–38), with an open text- 
box for further comment(s). Responses were collected anonymously 
from June 18 to September 24, 2020. 
Of the 489 responses received, 50 with no information beyond the 
demographics and 6 from non-MP professionals were excluded. Results 
from the 433 respondents were analysed overall, as well as by profes-
sional group and country cluster, where relevant. 
The largest professional groups were clinical MPs (N = 298, 69%) 
and head of medical physics/management (hereafter “management 
MPs”, N = 110, 25%). Fifteen research/academic physicists (3%) and 10 
with other or non-specified roles (2%) were only included in the overall 
analysis. 
Countries were divided into clusters according to the daily number of 
infections [1], with cluster A (N = 222, 51%) containing Italy, Spain, 
UK, USA, that were generally most affected by the pandemic. Cluster B 
(N = 156, 36%) contained countries such as Belgium, the Netherlands, 
Switzerland. Cluster C (N = 45, 10%) contained countries with low daily 
case numbers, with most responses from Norway and New Zealand (see 
supplementary material A.II for details). Ten responses were not 
included in any cluster, but only in the overall analysis, because either 
country was not indicated or was not included in the analysis of [1]. The 
majority (68%) of responses came from Europe followed by US/Canada 
(16%), New Zealand and Australia (7%), Asia and Middle East (7%), 
Latin America and Africa (~1% each). 
Demographics for clusters A and B were homogeneous (Supple-
mentary Table A.III). 
No response was mandatory and the number of responses per 
country were uneven. Therefore, no statistical analysis between sub- 
groups could be performed. 
3. Results 
3.1. Organisation of the department 
(Cluster) A-respondents were the most tested for COVID-19, and had 
the highest rates of positive/suspected patients and related treatment 
interruption (Table 1). The corresponding test rates and positive test 
rates were lower for B and lowest for C-respondents. A-respondents were 
more likely to be tested for COVID-19 after the first crisis peak, while B- 
respondents were more often tested before or at the crisis peak. 
The proportion of respondents working at home or on location was 
similar across clusters (Supplementary Fig. 1). Only a third of clinical 
MPs worked fully on-site. 
Thirty percent of A-respondents reported that there was no 
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contingency plan to handle the COVID-19 situation while for B and C- 
respondents this was 10% and 16%, respectively (Table 2). 
Three-quarters of respondents indicated some form of team splitting, 
mostly implemented by alternating people at home or at work with 
daily, weekly, or less frequently, early/late shifts. For small departments 
with 1–2 treatment units, 30% of respondents indicated there was no 
team splitting. This number was 23%, 16% and 21% for departments 
with 3–6 units, 7–10 units or 10 or more units respectively. Some other 
arrangements, aimed at minimizing contact at work, included groups 
on-site without contact or people working at home whenever possible. 
For just over half of the respondents, departments were not split into 
at risk/clean areas (Table 2). However, about a third of respondents’ 
departments, relatively homogeneous across clusters, were split. 
“Other” solutions involved having one COVID-linac or treating at-risk 
patients at the end of the day. 
Although remote access for planning was similar across the clusters 
(40%) before the pandemic, access increased more for A-respondents 
than for B and C-respondents during the pandemic. 
Access to personal protective equipment (PPE) was similar across 
clusters (Table 2). Yet 13 A-respondents and eight B-respondents re-
ported explicitly having no, or insufficient, equipment. Eight B-re-
spondents reported no such need because contact could be avoided. 
Some reported having specialized equipment (visor, high filtration 
masks) for brachytherapy. 
The percentage of physics staff staying away due to being infected 
was highest in cluster A and lowest in C (Table 2). The percentage 
staying away due to quarantine was higher than for infection, and 
cluster A had the highest rates. Other common reasons to stay away were 
risk factors or pregnancy (self or relative, 49 respondents), child-care 
(13), suspected infection/awaiting test results (8) or travel (self or 
Table 1 
Infection situation in the department by country cluster and overall.  








Were you tested for COVID-19 
(e.g. blood, nose/mouth 












4 (9%) 40 (9%) 




3 (7%) 62 (14%) 




2 (4%) 97 (22%)  
Was any patient COVID-positive 
(or suspected) treated in your 






















No response 1 0 0 1 (<1%)  
Did any patient have their 
treatment interrupted because 
of confirmed/suspected 






















No response 1 0 0 1 (<1%)  
a Ten responses are not associated with any cluster (see supplementary ma-
terial A.II). 
b this question referred to the first peak of the crisis (March–June 2020). 
Table 2 
Organisation of the department by country cluster and overall.  








How well prepared was the 
department for the COVID-19 
emergency? (Q13)     
Some contingency plan, but we 
had to develop the plan further 
























Other 1b 2 (1%)c 1 
(2%)d 
4 (<1%) 
No response 1 0 3 (7%) 4 (<1%)  
Did you divide the team? (Q14/ 
15)     
Yes split but not alternate (one 





4 (9%) 52 (12%) 













4 (9%) 100 (23%) 




3 (7%) 53 (12%) 
No response 0 1 
(<1%) 
0 1 (<1%)  
Did you divide the department 
into clean/at risk areas? 















Other (see text for description) 11 (5%) 13 (8%) 4 (9%) 29 (7%) 
No response 2 
(<1%) 
3 (2%) 2 (4%) 7 (2%)  
Did you have the means to work 
remotely in planning? (Q17)     































4 (9%) 63 (14%) 
Other 9 (4%) 10 (6%) 0 19 (4%) 




0 3 (<1%)  
Was the physics personnel 
screened daily for COVID 















No response 0 1 
(<1%) 
4 (9%) 1 (<1%)  
Which personal protective 
equipment was available 
from the hospital for MPs at 






















Protective glasses 4 (9%) 59 (14%) 
(continued on next page) 
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relative, 6). Two respondents reported that staff remained at home 
because of pandemic-related anxiety or distress. 
3.2. Changes in practice 
This section is based on 411 responses. The most widely imple-
mented change was increased use or implementation of hypofractiona-
tion (193 responses, 47%, Fig. 1). This was more prevalent in cluster A 
(54%) and in large-volume centres (4000+patients/year, 70%). 
Decreased gating use and increased simultaneous integrated boost (SIB) 
use was reported by 11% of respondents. Overall, 156 (38%) re-
spondents implemented no changes in techniques (15% for large- 
volume centres). 
In addition, 16 respondents observed a reduction in RT and 11 
mentioned postponing prostate RT with longer hormone treatment 
instead. Fifty-six (14%) respondents (37 from cluster A) observed a 
workload increase, including 13 where RT was given instead of surgery 
and/or chemotherapy. Six had more head and neck referrals; five had 
additional data collection or reporting; and four reported increased 
workloads due to initial replanning or additional QA for hypofractio-
nated treatments. 
PSQA and machine QA procedures were changed/reduced by 16% 
and 21% of respondents respectively (Table 3). For 25%, QA was moved 
to weekend or evenings to limit interactions. Others often did QA 
“whenever possible”. 
Overall, 49% of respondents did not need changes to compensate for 
extra time for cleaning/sterilizing rooms after treating COVID-positive 
patients, while 17% and 18% extended working hours and reduced 
patient numbers, respectively (Table 3). Thirteen respondents indicated 
that no COVID-positive/suspected patients had been treated in their 
department. Twelve reported that the reduced patient numbers 
compensated for the extra cleaning time. 
Most respondents reported that treatment unit technical support was 
available (Supplementary Table A.IV). Preventive maintenance was 
cancelled for 30% of A-respondents, 22% of B and 27% of C. Re-
placements of the high-dose rate/pulsed-dose rate afterloader sources 
were generally carried out as planned. 
Some MPs participated in COVID-related research initiatives: 49 
respondents reported that MPs helped design databases, 48 collected 
data (e.g. cone-beam CT), 15 participated in radiomics studies, eight 
investigated low-dose RT as COVID-19 treatment, four wrote papers on 
their experience and one investigated mask sterilization. 
Table 2 (continued ) 























3 (7%) 62 (14%)  
What proportion of your 
physics staff had to stay away 
from the department for 
COVID-related reasons? 
(Q20)     












3 (7%) 66 (15%) 
10–25% 19 (9%) 9 (6%) 1 (2%) 29 (7%) 
25–50% 6 (3%) 5 (3%) 0 11 (3%) 
>50% 0 3 (2%) 0 3 (<1%) 
No response/do not know 26 
(12%) 
14 (9%) 7(16%) 49 (12%)  
Due to going into isolation (e.g. 
household member infected/ 






















25–50% 9 (4%) 6 (4%) 1 (2%) 17 (4%) 
>50% 1 
(<1%) 
3 (2%) 2 (4%) 6 (1%) 
No response/do not know 20 
(90%) 
13 (8%) 4 (9%) 39 (9%)  
a Ten responses are not associated with any cluster (see supplementary ma-
terial A.II). 
b Describes a quick adaption to COVID-19. 
c One had no plan initially, then developing their approach then hospital-wide 
plan in place. One had a plan before the emergency started. 
d Well-developed department plan but hospital-wide plan lagged behind. 
Fig. 1. Changes in treatment technique (Q21) overall (red box), by country cluster (left of the dotted line) and by centre size in patients treated per year (right of the 
dotted line). Ten responses not associated to any cluster and 25 responses without an answer for the number of patients treated per year are only included in the 
“Overall” group. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) 
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3.3. Morale and mental health 
This section is based on 410 responses. To keep the team united 
during the pandemic, 282 (69%) respondents used email, 199 (49%) 
texting groups, 108 (26%) voice-only teleconference, 195 (48%) video- 
conferencing, 143 (35%) communication and collaboration platforms, 
and 124 (30%) on-site face-to-face meetings. 
Additionally, 20 respondents reported virtual social interactions. 
Fifteen respondents reported that staff had supported each other (as a 
personal initiative). Four wrote that the lack of support had been hard on 
them, while seven indicated there was no need for any support. Eight 
people mentioned increased flexibility in working time, six that there 
was some kind of support, and six mentioned psychological support 
available at various levels. 
3.4. Future impact 
This section is based on 406 responses. Over all professional groups, 
more respondents noted an increase, rather than a decrease, in trust 
between team members (Fig. 2). For management MPs, responses indi-
cated an increased feeling of team unity and trust in leadership. How-
ever, for clinical MPs, the tendency was reversed. 
Over 70% of respondents, over all professional groups, reported that 
working from home had become more acceptable and 48% reported that 
flexible working had become more acceptable. Forty percent of re-
spondents reported the use of new online tools. Sixty-eight percent of 
respondents would like home-working to remain after the pandemic and 
a slightly lower number believes that is likely (Fig. 3). Regarding clinical 
practice, there is some interest in keeping more hypofractionation after 
the pandemic and a similar number said that is likely. Generally, wishes 
and likeliness for changes was evaluated slightly higher by management 
MPs than by clinical MPs. Some respondents noted other things they 
would like to remain: paperless clinics (9), online meetings (6), flexible 
working (5) and more online conferences or exams (5). Few respondents 
(45 overall, 11%) hope that no changes will remain after the pandemic. 
The majority of respondents (83%) were not concerned about pres-
sure to keep changes made to cope with increased workload, but 48 
(12%) had concerns (14% of management, 12% of clinical MPs). Among 
these, 21 mentioned pressure for out-of-hours work (week-end, eve-
nings). Seven were concerned about increased workloads or less time/ 
staff for the same amount of work. 
Finally, other comments shared at the end of the survey generally 
indicated a willingness to learn and reflect on the changes necessitated 
by COVID-19. Some wrote that they were proud of their team and 
management and of how they had been well prepared. In contrast, 
others were disappointed in management and/or felt unheard. Uned-
ited, anonymous comments are available in supplementary material A. 
IV. 
4. Discussion 
We report on the experience of 433 MPs from 40 countries world-
wide during the early stage of the COVID-19 pandemic. Overall, they 
observed substantial changes in working situations and their in-
stitution’s clinical practice. Shift working with weekly alternation at- 
home/on-site with minimal contact and the use of PPE was frequently 
adopted to limit the infection risk for clinical MPs. 
Countries were grouped in clusters based on COVID-19 data up to 
April 12, 2020 [1] while responses were collected between June- 
September 2020. The cluster-based analysis may be biased with 
certain countries or centres being over-represented. Moreover, because 
the situation is highly dynamic, this survey should be considered a 
snapshot in time. Different pandemic stages have been identified as 
“early pandemic scenario” aiming for contingency standard of care and 
“late pandemic scenario” anticipating more drastic resource shortages 
and patient triage [19,20]. A-countries had typically reached the latter 
stage early, while C-countries mostly remained in the early stage at the 
survey time and could learn from A-countries experience. This differ-
ence in burden on healthcare systems was reflected in the department 
infection situation and organisation (Tables 1 and 2). A-respondents had 
the highest numbers of infected staff or those staying away from the 
department and the most infected/suspected patients. They were also 
most tested for COVID-19 but typically after the first peak, likely due to 
shortage of tests early in the pandemic, e.g. as reported in Spain [9]. 
Conversely, B-respondents were more often tested at the crisis start or 
peak (Table 1). Access to PPE at the first crisis peak for A-respondents 
was similar to other clusters. However, thirteen A-respondents reported 
having no or insufficient hospital-provided PPE, consistent with re-
ported PPE shortages [2,3], while some B-respondents reported not 
needing PPE because contact could be avoided. Having little patient 
contact, MPs might have had low priority for PPE access despite the risk 
of infection among colleagues. 
There was little difference in change of practice between clusters 
(Fig. 1, Table 3). Nevertheless, the most common change, 
Table 3 
Changes in QA practice and time required to sterilise the linac room by country 
cluster and overall.  








Did you change patient specific 
QA? (Q22)  







Reduction of pre-treatment QA 15 (7%) 4 (3%) 2 (5%) 23 (6%) 
Reduction or stopped in-vivo 
dosimetry (diodes) 
7 (3%) 3 (2%) 0 10 (2%) 
Increase use of EPID or other 
online in-vivo QA 
7 (3%) 5 (3%) 1 15 (4%) 
Increase use of remote 
automatic PSQA 
5 (2%) 2 (1%) 1 8 (2%) 
Other 13 (6%) 8 (6%) 3 (7%) 24 (6%)  
Did you change the tests for 
treatment unit QA? (Q23/24)  







Yes, we stopped yearly/ 
quarterly tests 
12 (6%) 6 (4%) 4 (9%) 23 (6%) 
Yes, we reduced tests frequency 14 (7%) 12 
(8%) 
4 (9%) 32 (8%) 
Yes, we reduced the number of 
tests 
14 (7%) 6 (4%) 0 22 (5%)  
Did you change the time for 
treatment unit QA? (Q25)  
















Other 14 (7%) 4 (3%) 1 (2%) 20 (5%) 
No response 6 (3%) 10 
(7%) 
3 (7%) 19 (5%)  
To compensate for the extra 
time needed to sterilise the 
linac room, after treating a 
COVID patient, RT/MP 
services needed to (Q29):  




4 (9%) 68 (17%) 























Acronyms: EPID: electronic portal imaging device. 
a 10 responses are not associated with any cluster (see supplementary material 
A.II). 
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implementation or increased use of hypofractionation (47% overall), 
was more predominant in cluster A (54%). The increase was markedly 
more common in centres with large patient numbers and it has been 
proposed extensively to reduce the patient presence in the hospital [12]. 
However, hypofractionation use is country-dependent [17,25] and for 
centres not yet applying it, implementation represents significant work, 
not easy to carry out under pressure [12]. Concerns around its level of 
evidence have also been raised which may have prevented wider 
implementation [12,20]. Despite its advantages, hypofractionation may 
involve increased MPs workload, from PSQA, first fraction verification, 
and initial replanning at implementation. Others reported that already 
planned hypofractionation implementation or paperless clinics, were 
accelerated by the pandemic. 
Certain medical physics tasks can, in principle, be performed 
remotely (e.g. treatment planning) or on-site outside of treatment hours 
(e.g. machine QA) [14]. Indeed, remote planning access was already 
available before COVID-19 for about 40% of respondents. However, 
14% of A-respondents and 29% of B and C-respondents had not yet got 
remote planning access during COVID-19. Khan et al. claim that the bulk 
of planning and plan checking could be performed remotely without 
quality loss [13], even if not supported by data. Although technically 
feasible, it has a cost and may be complicated by cyber-security and 
Fig. 2. Changes observed in working environment by professional group and overall. For a same colour, darker shades indicate an increase in unity/trust whereas a 
lighter shade indicates a decrease. 
Fig. 3. Changes in practice for the future that respondents wish to keep (in dark shades) and how likely they are to remain (light shades). Results are presented 
overall in the red box and for management and clinical MPs on the left and right of the dotted line respectively. (For interpretation of the references to colour in this 
figure legend, the reader is referred to the web version of this article.) 
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data-privacy perspectives [26,27]. Adequate equipment (e.g. computer 
hardware, fast internet connection) may be required for efficient and 
comfortable home-working for MPs. A full health and safety assessment 
for home-working environments should be considered, as Whitaker et al. 
recommend [14], if it becomes routine practice. 
Concerning on-site QA tasks, 16% and 21% of respondents changed 
PSQA and reduced machine QA, respectively (Table 3). A quarter of 
respondents moved QA to different times, often weekend or evening. 
These changes align with Khan et al. who reported prioritisation of QA 
tasks and moving QA to evenings/weekends or early morning before 
first patient [13]. However, it is necessary to establish clear guidelines 
prioritising QA tasks/test frequency in the case of resource shortage. 
Within the interdisciplinary team, the workload involved in hypo-
fractionation implementation and PSQA should be accounted for when 
recommending regimen alteration, especially in emergency situations. 
Multiple reports have warned of expected increased workloads post- 
pandemic from deferred referrals and patient treatments [9,13,28,29]. 
For MPs, postponed QA and equipment servicing may also contribute to 
substantial workload increases [13]. Among respondents, there was 
clear interest in increasing working flexibility and home-working which 
may help in handling this backlog [13]. Although some changes such as 
the implementation of hypofractionation and home-working were 
welcomed, personal sacrifices were also reported. Twelve percent of 
respondents were concerned about pressure to maintain increased or 
out-of-hours workloads. Management MPs were as concerned as clinical 
MPs, indicating that this pressure may come from higher in the 
department or hospital management. 
Interestingly, respondents indicated overall that there had been 
increased trust between team members (Fig. 2), but the tendencies 
regarding trust in leadership and team unity were reversed between 
management MPs (towards increased trust and unity) and clinical MPs 
(towards a decrease). This contradiction is concerning given that the 
perception of being valued by the supervisor was related to decreased 
burnout-risk among MPs [30] and trust in leadership rests on a fragile 
balance of mutual trust and transparent communication [31,32]. While 
some respondents indicated specific actions to keep the team united and 
maintain social interaction, some also reported suffering from the situ-
ation. Although virtual social interactions increased over the past year, 
some people might remain isolated with a risk of increased anxiety and 
depression symptoms [15]. Reaching out to colleague to keep social 
interaction may be an easy but effective way to maintain moral. 
One main limitation of the study is the sparsity of the data: a 
response was not mandatory for any of the questions (to encourage a 
high response rate); a small number of responses were received from 
research MPs; and the number of responses per country was uneven with 
most responses coming from Europe. The second main limitation is that 
the data was collected in late summer 2020 in a highly dynamic situa-
tion. Nevertheless, our results indicate possible underlying causes and 
mechanisms of medical physics practice adaptation. The changes 
deployed to deal with the pandemic have highlighted that certain tasks 
can sometimes be performed more efficiently, from one or more, or 
combinations of, process and work alterations, (e.g. remote working, use 
of online systems, working pattern modifications). Some are viewed 
positively by staff, but others have the potential to add stress in the 
longer term or be more difficult to manage and sustain and so need 
careful discussion and be acceptable to the staff involved. As of February 
2021, a majority of staff in Europe had received their first vaccination 
dose but 76% of department heads were concerned about their em-
ployees’ mental health, risk of burnout and well-being at work, 
acknowledging the effect of the pandemic on workload and work-life 
balance [33]. A year on, remote training and (continuous) education 
have also been widely implemented [34]. As live or blended courses and 
congresses are being offered again [35], the opportunity for broader 
access in the virtual world should be exploited. The increased use of 
automation and hypofractionation will likely be accelerated by COVID- 
19 and guidelines on the prioritization of QA tasks in case of future 
resource shortage are expected in the short term but should be based on 
international consensus. 
The challenge, looking ahead post-pandemic, is to optimize resource- 
use while maintaining treatment quality and safety and ensure an 
equitable workload and sustainable working conditions for all pro-
fessions. This task should include all stakeholders and further qualitative 
assessment via focus groups and/or new surveys to capture the evolution 
of clinical practice and COVID-19′s long-lasting effects. As previous re-
ports considered the lessons learned from the oncologists [24] or RTTs 
[18] perspective, we hope that this report can constitute a basis to start 
this multi-disciplinary assessment from the medical physics perspective. 
In conclusion, MPs have reported a large impact of COVID-19 on 
their work, depending on the number of daily infections in their country. 
This caused changes in practice such as increased use/implementation 
of hypofractionation and reorganisation of machine and patient-specific 
QA. The impact of these changes on team unity and trust in leadership 
has been perceived differently by management and clinical MPs. 
Although some changes were welcomed, there were also personal sac-
rifices. We hope this data will help reflect on the impact of this evolution 
on MPs for future crisis scenarios but also in regular practice. 
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